About LSIT
Board of Directors
Chairman of the Board
Elaine Wuertz
Life Science Innovation and Informatics Program Manager, Office of the CSO, Accelrys
Vice Chairman of the Board
Beth Everett, Ph.D.
AVP Business Consulting & Technology Services,
SAIC
Board Members:
Geoffrey Odell
Vice President & Global Head - Development IT, Novartis Pharmaceuticals Corporation
Chairman of the Board 2005~2007, LSIT Global Institute
Beth Kennedy
Informatics Site Head, Pfizer Global Research and Development
Greg Caressi
Senior Vice President, Healthcare & Life Sciences, Frost & Sullivan
Alan Edwards
President & CEO, Lansbrit Resources Ltd.
Anette Asher
Executive Director, LSIT Global Institute
Jonathan Morris, M.D.
CEO, ProSanos Corporation
Howard R. Asher
President, CEO, Global Life Sciences, Inc.
Founder, Chairman of the Board 2003~2005, LSIT Global Institute
Andrew Jacobson, Ph.D.
Chair, LSIT Technology Advisory Board
Chair (Interim), LSIT Industry Advisory Board
Paul Laskin
CEO, Etechnico
Terry L. Schmidt DrHA
Healthcare Executive
Gerry Martin
Ret. Vice President, Abbott Laboratories
Steven Fouskarinis
LSIT Corporate Secretary
About the Board
All activities of the LSIT Global Institute are managed by a Board of Directors. Directors are selected for their expertise in IT, the life sciences and regulatory affairs. Directors serve two-year, staggered terms. They have final authority over all Institute business, hire and supervise the executive staff (a president, a secretary/treasurer, and other staff members as needed), and control the budget. The Board of Directors appoints individuals to serve on the Technology Advisory Board. The daily affairs of the Institute will be conducted by the President, who supervises the initiatives and is responsible to the Board of Directors for the Institute's performance.
